Are children after liver transplant more prone to non-alcoholic fatty liver disease?

Pediatric Transplantation

Volumn 12, Issue 6, 2008, Pages 611-613

  Nobili, Valerio ^a   Dhawan, Anil ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; STEROID; TACROLIMUS;

CHILD; DIABETES MELLITUS; EDITORIAL; FATTY LIVER; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INFECTION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; OSTEOPOROSIS; PHENOTYPE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RECURRENT DISEASE; SURGICAL RISK; SURVIVAL;

CHILD; CHILD, PRESCHOOL; FATTY LIVER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 49349098046     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00927.x     Document Type: Editorial

References (19)

1. Darwish AA, Bordeaux C, Kader AH, et al. Pediatric liver transplantation using left hepatic segments from living related donors: Surgical experience in 100 recipients at Saint-Luc University Clinics. Pediatric Transplant 2006: 10: 345 353.
2. Taylor R, Franck LS, Gibson F, Dhawan A. A critical review of the health-related quality of life of children and adolescents after liver transplantation. Liver Transpl 2005: 11: 51 60 discussion 7 9.
3. Vilca-Melendez H, Heaton ND. Paediatric liver transplantation: The surgical view. Postgrad Med J 2004: 80: 571 576.
4. Muiesan P, Vergani D, Mieli-Vergani G. Liver transplantation in children. J Hepatol 2007: 46: 340 348.
5. Laryea M, Watt KD, Molinari M, et al. Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events. Liver Transpl 2007: 13: 1109 1114.
6. Poordad F, Gish R, Wakil A, Garcia-Kennedy R, Martin P, Yao FY. De novo non-alcoholic fatty liver disease following orthotopic liver transplantation. Am J Transplant 2003: 3: 1413 1417.
7. Contos MJ, Cales W, Sterling RK, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001: 7: 363 373.
8. Seo S, Maganti K, Khehra M, et al. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 2007: 13: 844 847.
9. Humar A, Crotteau S, Gruessner A, et al. Steroid minimization in liver transplant recipients: Impact on hepatitis C recurrence and post-transplant diabetes. Clin Transplant 2007: 21: 526 531.
10. Matsumoto T, Yamasaki S, Arakawa A, et al. Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits. Pathol Int 2007: 57: 388 389.
11. Lim LG, Cheng CL, Wee A, et al. Prevalence and clinical associations of posttransplant fatty liver disease. Liver Int 2007: 27: 76 80.
12. Fujikawa T, Fujita S, Mizuno S, et al. Clinical and financial impact of obesity on the outcome of liver transplantation. Transplant Proc 2006: 38: 3612 3614.
13. Treem WR. Beyond five years: Long-term follow-up in pediatric liver transplantation. Curr Gastroenterol Rep 2007: 9: 230 236.
14. Jankowska I, Socha P, Pawlowska J, et al. Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy. Pediatr Transplant 2007: 11: 796 798.
15. Tumgor G, Ankan C, Nart D, Kihic M, Aydogdu S. Fatty liver due to high levels of serum tacrolimus after liver transplantation. Turk J Pediatr 2007: 49: 223 225.
16. Trotter JF, Wachs ME, Trouillot TE, et al. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. Liver Transpl 2001: 7: 401 408.
17. Kniepeiss D, Iberer F, Schaffellner S, Jakoby E, Duller D, Tscheliessnigg K. Dyslipidemia during sirolimus therapy in patients after liver transplantation. Clin Transplant 2004: 18: 642 646.
18. Yoshida EM, Buczkowski AK, Sirrs SM, et al. Post-transplant diabetic ketoacidosis - A possible consequence of immunosuppression with calcineurin inhibiting agents: A case series. Transpl Int 2000: 13: 69 72.
19. Alisi A, Nobili V. Molecular genetics of NASH: The role of polymorphisms. J Hepatol 2007: 47: 868 869.